Quesra Latest Questions

CAR-T Cell Therapy market Trends, Analysis by 2035

jameshebrew
Newbie

You must login to add an answer.

1 Answer

  1. CAR-T cell therapies have been shown to enable complete disease remission, omitting the need for any further treatment. Several studies have proven the efficacy of these therapy candidates.   Driven by the ongoing pace of innovation and sufficient financial support from investors, the CAR-T celRead more

    CAR-T cell therapies have been shown to enable complete disease remission, omitting the need for any further treatment. Several studies have proven the efficacy of these therapy candidates.

     

    Driven by the ongoing pace of innovation and sufficient financial support from investors, the CAR-T cell therapy market is anticipated to witness substantial growth in the foreseen future

     

    The financial opportunity within the CAR-T cell therapy market has been analyzed across the following segments:

     

    • Target Indication(s)
    • Non-Hodgkin’s Lymphoma
    • Multiple Myeloma
    • Acute Lymphoblastic Leukemia
    • Chronic Lymphocytic Leukemia
    • Hodgkin’s Lymphoma
    • Acute Myeloid Leukemia
    • Ovarian Cancer
    • Generalized Myasthenia Gravis (MG)
    • Renal Cell Carcinoma

     

    • Target Antigen
    • CD19
    • BCMA
    • CD19/22
    • Others

     

    • Key Geographical Regions
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and North Africa
    • Rest of the World

     

    The Global CAR-T Cell Therapy Market (4th Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:

    • Autolus
    • bluebird Bio
    • Bristol Myers Squibb
    • Carsgen Therapeutics
    • Cellectis
    • Cellular Biomedicine Group
    • Gilead Sciences
    • Innovative Cellular Therapeutics
    • Kuur Therapeutics
    • Noile-Immune Biotech
    • Novartis
    • Shanghai GeneChem
    • Sinobioway Cell Therapy
    • Takara Bio
    • Wellington Zhaotai Therapies

     

    Table of Contents

     

    1. Preface      
    2. Executive Summary
    3. Introduction
    4. CAR-T Cell Therapies: Market Landscape
    5. Key Insights
    6. Clinical Trial ANALYSIS
    7. Key Opinion Leaders
    8. CAR-T Cell Therapy Profiles
    9. Partnerships And Collaborations
    10. Funding And Investment Analysis
    11. Patent Analysis
    12. Case Study: Cell Therapy Manufacturing
    13. Cost Price Analysis
    14. Market Forecast and Opportunity Analysis
    15. Promotional Analysis
    16. Company Profiles
    17. Concluding Remarks
    18. Executive Insights
    19. Appendix 1: Tabulated Data
    20. Appendix 2: List of Companies and Organizations

     

    Get more details on the CAR-T Cell Therapy Market report https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html

     

    You may also be interested in the following titles:

    4D Bioprinting Market
    Non-Viral / Intracellular Drug Delivery Systems Market

     

    You may also like to learn what our experts are sharing in Roots educational series:

    Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic?
    Exploring How Artificial Intelligence Is Transforming Digital Pathology

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415

    Ben.johnson@rootsanalysis.com

     

    See less